While new natural drugs are rushing, steady sellers have decreased

It is known that new natural drugs, such as the ‘Motilitone’ self-developed by Dong-A ST, the PMG’s ‘Layla’ co-marketed by Ahn-gook Pharm and the Green Cross’s ‘Shinbaro’ launched as not only a capsule but refinement, have strengthened its positions in the domestic market last year.

On the other hand, the Dong-A ST‘s ‘Stillen’ that once recorded KRW 80 billion sales, the SK Chemicals’s ‘Joins’...